These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8211202)

  • 1. Monoclonal antibody therapy for indolent lymphomas.
    Grossbard ML; Nadler LM
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):118-35. PubMed ID: 8211202
    [No Abstract]   [Full Text] [Related]  

  • 2. [New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies].
    Buske C; Feuring-Buske M; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 1999 Jul; 124(27):842-7. PubMed ID: 10432945
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patients.
    Coiffier B
    Haematologica; 1999 Jun; 84 Suppl EHA-4():14-8. PubMed ID: 10907457
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted monoclonal antibody therapy and radioimmunotherapy for lymphoproliferative disorders of the ocular adnexa.
    Shome D; Esmaeli B
    Curr Opin Ophthalmol; 2008 Sep; 19(5):414-21. PubMed ID: 18772675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody (MoAb) therapy in non-Hodgkin's lymphomas.
    Lim SH; Marcus RE
    Blood Rev; 1992 Sep; 6(3):157-62. PubMed ID: 1422284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
    Leonard JP; Gregory SA; Maloney DG; Vose JM; Younes A; Zelenetz AD
    Clin Adv Hematol Oncol; 2008 Jun; 6(6):437-45. PubMed ID: 18567989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies and immunoconjugates.
    Press OW
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S19-26. PubMed ID: 9672771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal antibody therapy for malignant lymphoma].
    Buske C; Dreyling M; Unterhalt M; Hiddemann W
    Med Klin (Munich); 2005 Jan; 100(1):14-24. PubMed ID: 15654538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody therapy for non-Hodgkin's lymphoma.
    Ansell SM
    Curr Opin Mol Ther; 2004 Apr; 6(2):175-81. PubMed ID: 15195930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging treatments for indolent lymphoma.
    Cheson BD; Gregory SA; Marcus R
    Clin Adv Hematol Oncol; 2007 May; 5(5 Suppl 8):1-9; quiz 11-2. PubMed ID: 17637594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inroads in the therapy of indolent lymphomas: exploiting biological insights.
    McLaughlin P
    Cancer Invest; 1999; 17(1):73-86. PubMed ID: 10999051
    [No Abstract]   [Full Text] [Related]  

  • 12. Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma.
    McCune SL; Gockerman JP; Rizzieri DA
    JAMA; 2001 Sep; 286(10):1149-52. PubMed ID: 11559240
    [No Abstract]   [Full Text] [Related]  

  • 13. New therapeutic approaches to non-Hodgkin's lymphomas.
    Lambert JF; Elfenbein GJ
    Med Health R I; 2003 Aug; 86(8):236-9. PubMed ID: 14582217
    [No Abstract]   [Full Text] [Related]  

  • 14. [Radioimmunoconjugates: therapy of non-Hodgkin lymphomas and colorectal carcinomas].
    Griesinger F; Trümper L; Becker W
    Internist (Berl); 2001 Jun; 42(6):860-4, 866-73. PubMed ID: 11449633
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioimmunotherapy for non-Hodgkin's lymphomas: a historical perspective.
    Press OW
    Semin Oncol; 2003 Apr; 30(2 Suppl 4):10-21. PubMed ID: 12728403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal antibodies in therapy of malignant lymphomas].
    Buske C; Engert A; Schnell R; Diehl V; Hiddemann W
    Internist (Berl); 1998 Dec; 39(12):1205-14. PubMed ID: 10198827
    [No Abstract]   [Full Text] [Related]  

  • 17. A revolution in the treatment of non-Hodgkin's lymphoma.
    DeNardo GL; O'Donnell RT; Oldham RK; DeNardo SJ
    Cancer Biother Radiopharm; 1998 Aug; 13(4):213-23. PubMed ID: 10850358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal antibodies and immunoconjugates: new prospects in the treatment of non-Hodgkin's lymphomas].
    Sack A; Meusers P
    Strahlenther Onkol; 1999 Apr; 175(4):192-3. PubMed ID: 10230466
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody-targeted therapy for low-grade lymphoma.
    Vose JM
    Semin Hematol; 1999 Oct; 36(4 Suppl 6):15-20. PubMed ID: 10530712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody.
    Wiseman GA; White CA; Witzig TE; Gordon LI; Emmanouilides C; Raubitschek A; Janakiraman N; Gutheil J; Schilder RJ; Spies S; Silverman DH; Grillo-López AJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3281s-3286s. PubMed ID: 10541376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.